Goal-directed resuscitation for patients with early septic shock
ARISE trial design and results
Design
Multicentre randomised controlled trial
Treatment
Early goal-directed therapy
Control
Usual care
Population
1600 patients presenting to the emergency department with early septic shock
Follow-up
90 days
Primary endpoint
All-cause mortality at 90 days
Result
796 patients were assigned to early goal-directed therapy and 804 to usual care, with primary outcome data available for over 99%. The EGDT group received a larger mean volume of intravenous fluid and more vasopressors and transfusions, without any reduction in 90-day mortality.
Secondary endpoints
Organ support, length of stay, quality of life
In critically ill patients presenting to the emergency department with early septic shock, EGDT did not reduce all-cause mortality at 90 days.
The trial authors, in the published abstract
How it has aged
The second replication failure, in Australasia. Together with ProCESS and ProMISe it produced an unusually clean verdict on a practice that had already been embedded in international guidelines and quality metrics.
Publications
Goal-directed resuscitation for patients with early septic shock
Peake SL, Delaney A, Bailey M, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014 Oct 16;371(16):1496-506.
No reduction in 90-day all-cause mortality
More fluid, vasopressors and transfusion in the EGDT arm